跳至主要内容
临床试验/NCT03179592
NCT03179592已完成不适用

VOLtage-based Contrast Media AdaptatioN in Coronary Computed Tomography Angiography (VOLCANIC-CTA): A Prospective Trial

Medical University of South Carolina1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2017年3月22日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
Qualitative assessment of image quality

研究概览

简要总结

The purpose of this study is to prospectively evaluate the effectiveness of low-volume contrast media (CM) injection protocols adapted to tube voltage in patients undergoing Coronary Computed Tomography Angiography (CCTA).

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Other

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Referred for a clinically indicated CCTA scan.
  • Subject must be 18 - 85 years of age.
  • Subject must provide written informed consent prior to any study-related procedures being performed.
  • Subject must be willing to comply with all clinical study procedures.

排除标准

  • Subject is a pregnant or nursing female. Exclude the possibility of pregnancy:
  • By testing (serum or urine beta HCG) within 24 hours before study agent administration, or
  • By surgical sterilization, or
  • Post-menopausal, with minimum one (1) year history without menses.
  • Subject is chosen by the automated tube voltage selection algorithm (or adjusted by the technologist) to be scanned using a tube voltage that is not 70, 80, 90, 100, 110, 120, or 130 kV.
  • Subject is chosen by the automated tube voltage selection algorithm (or adjusted by the technologist) to be scanned using a tube voltage that has previously reached the maximum subject number (20 subjects per tube voltage).
  • Subject has an acute psychiatric disorder.
  • Subject is unwilling to comply with the requirements of the protocol.
  • Subject has previously entered this study.
  • Subject has an allergy against iodinated contrast agents or pharmaceutical stressors used in this study.
  • Subject has impaired renal function (creatinine > 1.5 mg/dl).
  • Subject is in unstable condition.

研究组 & 干预措施

Low-volume contrast media injection protocol

Patients will receive a low-volume contrast media (Ultravist 370Mg I/Ml Solution for Injection) injection protocol that is tailored to a specific tube voltage. Tube voltages will be automatically selected by the scanner to be used for the CCTA acquisition.

干预措施: Ultravist 370Mg I/Ml Solution for Injection (Drug)

结局指标

主要结局

Qualitative assessment of image quality

时间窗: 2 years

This will be performed by two independent observers using a semi-quantitative rating scale of 1 - 5. Image quality will be graded on a five-point scoring system: 1 non-diagnostic; 2 limited diagnostic value; 3 adequate (presence of artifacts not limiting detection of luminal stenosis); 4 good; 5 excellent. Image quality assessments will be performed on both the investigative and control groups.

Quantitative assessment of image quality

时间窗: 2 years

Measurements and calculations will be performed by two independent observers who will be blinded to image acquisition parameters. Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) will be measured for all images.

次要结局

  • Radiation dose of coronary CTA(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

VOLtage-based Contrast Media AdaptatioN in Coronary... | 临床试验